nodes	percent_of_prediction	percent_of_DWPC	metapath
Metaraminol—ADRA1A—polycystic ovary syndrome	0.934	1	CbGaD
Metaraminol—ADRA1A—Adrenoceptors—ADRA1D—polycystic ovary syndrome	0.00489	0.0883	CbGpPWpGaD
Metaraminol—ADRA1A—Adrenoceptors—ADRA1B—polycystic ovary syndrome	0.00476	0.0859	CbGpPWpGaD
Metaraminol—ADRA1A—Adrenoceptors—ADRB3—polycystic ovary syndrome	0.00347	0.0626	CbGpPWpGaD
Metaraminol—ADRA1A—Adrenoceptors—ADRB2—polycystic ovary syndrome	0.00187	0.0338	CbGpPWpGaD
Metaraminol—ADRA1A—AMPK Signaling—ADIPOR1—polycystic ovary syndrome	0.00178	0.032	CbGpPWpGaD
Metaraminol—ADRA1A—AMPK Signaling—ADIPOR2—polycystic ovary syndrome	0.00178	0.032	CbGpPWpGaD
Metaraminol—Methoxamine—ADRA1D—polycystic ovary syndrome	0.00175	0.165	CrCbGaD
Metaraminol—ADRA1A—Monoamine GPCRs—ADRA1D—polycystic ovary syndrome	0.00173	0.0312	CbGpPWpGaD
Metaraminol—ADRA1A—Monoamine GPCRs—ADRA1B—polycystic ovary syndrome	0.00168	0.0304	CbGpPWpGaD
Metaraminol—Methoxamine—ADRA1B—polycystic ovary syndrome	0.00149	0.14	CrCbGaD
Metaraminol—ADRA1A—Amine ligand-binding receptors—ADRA1D—polycystic ovary syndrome	0.00145	0.0262	CbGpPWpGaD
Metaraminol—ADRA1A—Amine ligand-binding receptors—ADRA1B—polycystic ovary syndrome	0.00141	0.0255	CbGpPWpGaD
Metaraminol—ADRA1A—Monoamine GPCRs—ADRB3—polycystic ovary syndrome	0.00123	0.0222	CbGpPWpGaD
Metaraminol—ADRA1A—G alpha (12/13) signalling events—PLEKHG5—polycystic ovary syndrome	0.00107	0.0193	CbGpPWpGaD
Metaraminol—ADRA1A—Amine ligand-binding receptors—ADRB3—polycystic ovary syndrome	0.00103	0.0186	CbGpPWpGaD
Metaraminol—ADRA1A—AMPK Signaling—INS-IGF2—polycystic ovary syndrome	0.00102	0.0184	CbGpPWpGaD
Metaraminol—Methoxamine—ADRA1A—polycystic ovary syndrome	0.001	0.0945	CrCbGaD
Metaraminol—ADRA1A—AMPK Signaling—ADRA1B—polycystic ovary syndrome	0.000933	0.0168	CbGpPWpGaD
Metaraminol—Phenylephrine—ADRA1D—polycystic ovary syndrome	0.000917	0.0864	CrCbGaD
Metaraminol—ADRA1A—G alpha (12/13) signalling events—ADRA1D—polycystic ovary syndrome	0.000897	0.0162	CbGpPWpGaD
Metaraminol—ADRA1A—G alpha (12/13) signalling events—ADRA1B—polycystic ovary syndrome	0.000872	0.0157	CbGpPWpGaD
Metaraminol—Phenylephrine—ADRA1B—polycystic ovary syndrome	0.000782	0.0737	CrCbGaD
Metaraminol—ADRA1A—Monoamine GPCRs—ADRB2—polycystic ovary syndrome	0.000663	0.012	CbGpPWpGaD
Metaraminol—ADRA1A—Endothelin Pathways—GNAS—polycystic ovary syndrome	0.000615	0.0111	CbGpPWpGaD
Metaraminol—Droxidopa—ADRA1D—polycystic ovary syndrome	0.000558	0.0526	CrCbGaD
Metaraminol—ADRA1A—Amine ligand-binding receptors—ADRB2—polycystic ovary syndrome	0.000557	0.0101	CbGpPWpGaD
Metaraminol—Phenylephrine—ADRA1A—polycystic ovary syndrome	0.000527	0.0496	CrCbGaD
Metaraminol—ADRA1A—Calcium Regulation in the Cardiac Cell—ADRA1D—polycystic ovary syndrome	0.000518	0.00935	CbGpPWpGaD
Metaraminol—ADRA1A—AMPK Signaling—INSR—polycystic ovary syndrome	0.000516	0.00931	CbGpPWpGaD
Metaraminol—ADRA1A—Calcium Regulation in the Cardiac Cell—ADRA1B—polycystic ovary syndrome	0.000504	0.00909	CbGpPWpGaD
Metaraminol—Droxidopa—ADRB3—polycystic ovary syndrome	0.000501	0.0472	CrCbGaD
Metaraminol—Droxidopa—ADRA1B—polycystic ovary syndrome	0.000476	0.0448	CrCbGaD
Metaraminol—Levonordefrin—ADRA1A—polycystic ovary syndrome	0.000455	0.0428	CrCbGaD
Metaraminol—ADRA1A—G alpha (q) signalling events—PTAFR—polycystic ovary syndrome	0.000445	0.00803	CbGpPWpGaD
Metaraminol—ADRA1A—G alpha (q) signalling events—ADRA1D—polycystic ovary syndrome	0.000432	0.00779	CbGpPWpGaD
Metaraminol—ADRA1A—AMPK Signaling—ADIPOQ—polycystic ovary syndrome	0.00043	0.00776	CbGpPWpGaD
Metaraminol—ADRA1A—AMPK Signaling—CCNB1—polycystic ovary syndrome	0.00043	0.00776	CbGpPWpGaD
Metaraminol—ADRA1A—G alpha (q) signalling events—ADRA1B—polycystic ovary syndrome	0.00042	0.00758	CbGpPWpGaD
Metaraminol—ADRA1A—AMPK Signaling—SLC2A4—polycystic ovary syndrome	0.000406	0.00733	CbGpPWpGaD
Metaraminol—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—PTAFR—polycystic ovary syndrome	0.000398	0.00718	CbGpPWpGaD
Metaraminol—Ephedrine—ADRA1A—polycystic ovary syndrome	0.000389	0.0367	CrCbGaD
Metaraminol—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—ADRA1D—polycystic ovary syndrome	0.000386	0.00697	CbGpPWpGaD
Metaraminol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—NPB—polycystic ovary syndrome	0.000377	0.00681	CbGpPWpGaD
Metaraminol—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—ADRA1B—polycystic ovary syndrome	0.000376	0.00678	CbGpPWpGaD
Metaraminol—ADRA1A—GPCRs, Class A Rhodopsin-like—PTGER3—polycystic ovary syndrome	0.000368	0.00663	CbGpPWpGaD
Metaraminol—ADRA1A—GPCRs, Class A Rhodopsin-like—LHCGR—polycystic ovary syndrome	0.000368	0.00663	CbGpPWpGaD
Metaraminol—ADRA1A—Calcium Regulation in the Cardiac Cell—ADRB3—polycystic ovary syndrome	0.000368	0.00663	CbGpPWpGaD
Metaraminol—Phenylpropanolamine—ADRA1A—polycystic ovary syndrome	0.000349	0.0329	CrCbGaD
Metaraminol—ADRA1A—GPCRs, Class A Rhodopsin-like—PTAFR—polycystic ovary syndrome	0.000344	0.00621	CbGpPWpGaD
Metaraminol—ADRA1A—GPCRs, Class A Rhodopsin-like—ADRA1D—polycystic ovary syndrome	0.000334	0.00602	CbGpPWpGaD
Metaraminol—ADRA1A—GPCRs, Class A Rhodopsin-like—ADRA1B—polycystic ovary syndrome	0.000325	0.00586	CbGpPWpGaD
Metaraminol—Droxidopa—ADRA1A—polycystic ovary syndrome	0.00032	0.0302	CrCbGaD
Metaraminol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—LHCGR—polycystic ovary syndrome	0.000315	0.00568	CbGpPWpGaD
Metaraminol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—PTGER3—polycystic ovary syndrome	0.000315	0.00568	CbGpPWpGaD
Metaraminol—ADRA1A—G alpha (q) signalling events—GNRH1—polycystic ovary syndrome	0.000296	0.00534	CbGpPWpGaD
Metaraminol—Pseudoephedrine—ADRA1A—polycystic ovary syndrome	0.000295	0.0278	CrCbGaD
Metaraminol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—PTAFR—polycystic ovary syndrome	0.000295	0.00532	CbGpPWpGaD
Metaraminol—ADRA1A—GPCR ligand binding—NPB—polycystic ovary syndrome	0.000287	0.00519	CbGpPWpGaD
Metaraminol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—ADRA1D—polycystic ovary syndrome	0.000286	0.00516	CbGpPWpGaD
Metaraminol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—ADRA1B—polycystic ovary syndrome	0.000278	0.00502	CbGpPWpGaD
Metaraminol—ADRA1A—GPCRs, Class A Rhodopsin-like—FSHR—polycystic ovary syndrome	0.000269	0.00486	CbGpPWpGaD
Metaraminol—ADRA1A—AMPK Signaling—LEP—polycystic ovary syndrome	0.000267	0.00482	CbGpPWpGaD
Metaraminol—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—GNRH1—polycystic ovary syndrome	0.000265	0.00478	CbGpPWpGaD
Metaraminol—ADRA1A—Calcium Regulation in the Cardiac Cell—CAMK2D—polycystic ovary syndrome	0.000265	0.00478	CbGpPWpGaD
Metaraminol—ADRA1A—GPCR ligand binding—PTGER3—polycystic ovary syndrome	0.00024	0.00433	CbGpPWpGaD
Metaraminol—ADRA1A—GPCR ligand binding—LHCGR—polycystic ovary syndrome	0.00024	0.00433	CbGpPWpGaD
Metaraminol—ADRA1A—GPCRs, Class A Rhodopsin-like—ADRB3—polycystic ovary syndrome	0.000237	0.00428	CbGpPWpGaD
Metaraminol—Ephedrine—ADRB2—polycystic ovary syndrome	0.000231	0.0218	CrCbGaD
Metaraminol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—FSHR—polycystic ovary syndrome	0.000231	0.00416	CbGpPWpGaD
Metaraminol—ADRA1A—GPCR ligand binding—PTAFR—polycystic ovary syndrome	0.000224	0.00405	CbGpPWpGaD
Metaraminol—ADRA1A—AMPK Signaling—AKT2—polycystic ovary syndrome	0.00022	0.00398	CbGpPWpGaD
Metaraminol—ADRA1A—GPCR ligand binding—ADRA1D—polycystic ovary syndrome	0.000218	0.00393	CbGpPWpGaD
Metaraminol—ADRA1A—GPCR ligand binding—ADRA1B—polycystic ovary syndrome	0.000212	0.00382	CbGpPWpGaD
Metaraminol—ADRA1A—GPCRs, Class A Rhodopsin-like—MTNR1B—polycystic ovary syndrome	0.000209	0.00378	CbGpPWpGaD
Metaraminol—Phenylpropanolamine—ADRB2—polycystic ovary syndrome	0.000207	0.0196	CrCbGaD
Metaraminol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—ADRB3—polycystic ovary syndrome	0.000203	0.00366	CbGpPWpGaD
Metaraminol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—LHB—polycystic ovary syndrome	0.000201	0.00362	CbGpPWpGaD
Metaraminol—ADRA1A—G alpha (q) signalling events—GHRL—polycystic ovary syndrome	0.0002	0.00361	CbGpPWpGaD
Metaraminol—ADRA1A—Calcium Regulation in the Cardiac Cell—ADRB2—polycystic ovary syndrome	0.000198	0.00358	CbGpPWpGaD
Metaraminol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—GNRH1—polycystic ovary syndrome	0.000196	0.00354	CbGpPWpGaD
Metaraminol—Droxidopa—ADRB2—polycystic ovary syndrome	0.00019	0.018	CrCbGaD
Metaraminol—ADRA1A—Calcium Regulation in the Cardiac Cell—GNAS—polycystic ovary syndrome	0.000184	0.00332	CbGpPWpGaD
Metaraminol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—MTNR1B—polycystic ovary syndrome	0.000179	0.00324	CbGpPWpGaD
Metaraminol—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—GHRL—polycystic ovary syndrome	0.000179	0.00323	CbGpPWpGaD
Metaraminol—ADRA1A—GPCR ligand binding—FSHR—polycystic ovary syndrome	0.000176	0.00317	CbGpPWpGaD
Metaraminol—Pseudoephedrine—ADRB2—polycystic ovary syndrome	0.000175	0.0165	CrCbGaD
Metaraminol—ADRA1A—GPCR downstream signaling—NPB—polycystic ovary syndrome	0.000162	0.00293	CbGpPWpGaD
Metaraminol—ADRA1A—GPCR ligand binding—ADRB3—polycystic ovary syndrome	0.000155	0.00279	CbGpPWpGaD
Metaraminol—ADRA1A—GPCR ligand binding—LHB—polycystic ovary syndrome	0.000153	0.00276	CbGpPWpGaD
Metaraminol—ADRA1A—GPCR ligand binding—GNRH1—polycystic ovary syndrome	0.000149	0.00269	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling by GPCR—NPB—polycystic ovary syndrome	0.000147	0.00266	CbGpPWpGaD
Metaraminol—ADRA1A—GPCR downstream signaling—PLEKHG5—polycystic ovary syndrome	0.000147	0.00265	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling Pathways—ARHGAP23—polycystic ovary syndrome	0.000144	0.0026	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling Pathways—ARHGAP30—polycystic ovary syndrome	0.000144	0.0026	CbGpPWpGaD
Metaraminol—ADRA1A—GPCR ligand binding—SCT—polycystic ovary syndrome	0.000143	0.00258	CbGpPWpGaD
Metaraminol—ADRA1A—GPCR ligand binding—MTNR1B—polycystic ovary syndrome	0.000137	0.00246	CbGpPWpGaD
Metaraminol—ADRA1A—GPCR downstream signaling—PTGER3—polycystic ovary syndrome	0.000136	0.00245	CbGpPWpGaD
Metaraminol—ADRA1A—GPCR downstream signaling—LHCGR—polycystic ovary syndrome	0.000136	0.00245	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling by GPCR—PLEKHG5—polycystic ovary syndrome	0.000133	0.00241	CbGpPWpGaD
Metaraminol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—GHRL—polycystic ovary syndrome	0.000132	0.00239	CbGpPWpGaD
Metaraminol—ADRA1A—GPCRs, Class A Rhodopsin-like—ADRB2—polycystic ovary syndrome	0.000128	0.00231	CbGpPWpGaD
Metaraminol—ADRA1A—GPCR downstream signaling—PTAFR—polycystic ovary syndrome	0.000127	0.00229	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling by GPCR—PTGER3—polycystic ovary syndrome	0.000123	0.00222	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling by GPCR—LHCGR—polycystic ovary syndrome	0.000123	0.00222	CbGpPWpGaD
Metaraminol—ADRA1A—GPCR downstream signaling—ADRA1D—polycystic ovary syndrome	0.000123	0.00222	CbGpPWpGaD
Metaraminol—ADRA1A—GPCR downstream signaling—ADRA1B—polycystic ovary syndrome	0.00012	0.00216	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling by GPCR—PTAFR—polycystic ovary syndrome	0.000115	0.00208	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling by GPCR—ADRA1D—polycystic ovary syndrome	0.000112	0.00202	CbGpPWpGaD
Metaraminol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—ADRB2—polycystic ovary syndrome	0.00011	0.00198	CbGpPWpGaD
Metaraminol—ADRA1A—GPCR downstream signaling—PDE3B—polycystic ovary syndrome	0.000109	0.00197	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling by GPCR—ADRA1B—polycystic ovary syndrome	0.000109	0.00196	CbGpPWpGaD
Metaraminol—ADRA1A—GPCR ligand binding—GHRL—polycystic ovary syndrome	0.000101	0.00182	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling Pathways—FLT4—polycystic ovary syndrome	9.97e-05	0.0018	CbGpPWpGaD
Metaraminol—ADRA1A—GPCR downstream signaling—FSHR—polycystic ovary syndrome	9.92e-05	0.00179	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling by GPCR—PDE3B—polycystic ovary syndrome	9.89e-05	0.00179	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling by GPCR—FSHR—polycystic ovary syndrome	9.01e-05	0.00163	CbGpPWpGaD
Metaraminol—ADRA1A—GPCR downstream signaling—ADRB3—polycystic ovary syndrome	8.73e-05	0.00158	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling Pathways—NPB—polycystic ovary syndrome	8.71e-05	0.00157	CbGpPWpGaD
Metaraminol—ADRA1A—GPCR downstream signaling—LHB—polycystic ovary syndrome	8.63e-05	0.00156	CbGpPWpGaD
Metaraminol—ADRA1A—GPCR downstream signaling—GNRH1—polycystic ovary syndrome	8.44e-05	0.00152	CbGpPWpGaD
Metaraminol—ADRA1A—GPCR ligand binding—ADRB2—polycystic ovary syndrome	8.35e-05	0.00151	CbGpPWpGaD
Metaraminol—ADRA1A—GPCR downstream signaling—SCT—polycystic ovary syndrome	8.09e-05	0.00146	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling by GPCR—ADRB3—polycystic ovary syndrome	7.93e-05	0.00143	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling Pathways—PLEKHG5—polycystic ovary syndrome	7.88e-05	0.00142	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling by GPCR—LHB—polycystic ovary syndrome	7.84e-05	0.00141	CbGpPWpGaD
Metaraminol—ADRA1A—GPCR ligand binding—GNAS—polycystic ovary syndrome	7.74e-05	0.0014	CbGpPWpGaD
Metaraminol—ADRA1A—GPCR downstream signaling—MTNR1B—polycystic ovary syndrome	7.71e-05	0.00139	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling by GPCR—GNRH1—polycystic ovary syndrome	7.66e-05	0.00138	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling by GPCR—SCT—polycystic ovary syndrome	7.34e-05	0.00133	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling Pathways—LHCGR—polycystic ovary syndrome	7.27e-05	0.00131	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling Pathways—PTGER3—polycystic ovary syndrome	7.27e-05	0.00131	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling by GPCR—MTNR1B—polycystic ovary syndrome	7.01e-05	0.00126	CbGpPWpGaD
Metaraminol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—POMC—polycystic ovary syndrome	6.84e-05	0.00123	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling Pathways—PTAFR—polycystic ovary syndrome	6.8e-05	0.00123	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling Pathways—ADRA1D—polycystic ovary syndrome	6.6e-05	0.00119	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling Pathways—ADRA1B—polycystic ovary syndrome	6.42e-05	0.00116	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling Pathways—INHBB—polycystic ovary syndrome	6.26e-05	0.00113	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling Pathways—PDE3B—polycystic ovary syndrome	5.84e-05	0.00105	CbGpPWpGaD
Metaraminol—ADRA1A—GPCR downstream signaling—GHRL—polycystic ovary syndrome	5.7e-05	0.00103	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling Pathways—FSHR—polycystic ovary syndrome	5.32e-05	0.00096	CbGpPWpGaD
Metaraminol—ADRA1A—GPCR ligand binding—POMC—polycystic ovary syndrome	5.21e-05	0.00094	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling by GPCR—GHRL—polycystic ovary syndrome	5.17e-05	0.000934	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling Pathways—RACGAP1—polycystic ovary syndrome	5e-05	0.000903	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling Pathways—FST—polycystic ovary syndrome	4.74e-05	0.000856	CbGpPWpGaD
Metaraminol—ADRA1A—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	4.72e-05	0.000851	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling Pathways—ADRB3—polycystic ovary syndrome	4.69e-05	0.000846	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling Pathways—LHB—polycystic ovary syndrome	4.63e-05	0.000836	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling Pathways—GNRH1—polycystic ovary syndrome	4.53e-05	0.000817	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling Pathways—AKR1C1—polycystic ovary syndrome	4.38e-05	0.000791	CbGpPWpGaD
Metaraminol—ADRA1A—GPCR downstream signaling—GNAS—polycystic ovary syndrome	4.37e-05	0.000789	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling Pathways—SCT—polycystic ovary syndrome	4.34e-05	0.000783	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling by GPCR—ADRB2—polycystic ovary syndrome	4.28e-05	0.000773	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling Pathways—MTNR1B—polycystic ovary syndrome	4.14e-05	0.000747	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling Pathways—FGF18—polycystic ovary syndrome	4.07e-05	0.000734	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling Pathways—RBP4—polycystic ovary syndrome	4.03e-05	0.000728	CbGpPWpGaD
Metaraminol—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—polycystic ovary syndrome	4.02e-05	0.000725	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling by GPCR—GNAS—polycystic ovary syndrome	3.97e-05	0.000717	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling Pathways—YAP1—polycystic ovary syndrome	3.77e-05	0.00068	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling Pathways—GAB1—polycystic ovary syndrome	3.71e-05	0.00067	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling Pathways—INSR—polycystic ovary syndrome	3.55e-05	0.000641	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling Pathways—AKR1C3—polycystic ovary syndrome	3.37e-05	0.000609	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling Pathways—TNRC6B—polycystic ovary syndrome	3.32e-05	0.000599	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling Pathways—PGR—polycystic ovary syndrome	3.29e-05	0.000593	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling Pathways—GHRL—polycystic ovary syndrome	3.06e-05	0.000552	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling Pathways—PLAT—polycystic ovary syndrome	3.06e-05	0.000552	CbGpPWpGaD
Metaraminol—ADRA1A—GPCR downstream signaling—POMC—polycystic ovary syndrome	2.94e-05	0.000531	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling Pathways—ATF1—polycystic ovary syndrome	2.92e-05	0.000526	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling Pathways—TCF7L2—polycystic ovary syndrome	2.84e-05	0.000513	CbGpPWpGaD
Metaraminol—ADRA1A—GPCR downstream signaling—AKT2—polycystic ovary syndrome	2.83e-05	0.000511	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling Pathways—NGFR—polycystic ovary syndrome	2.69e-05	0.000486	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling by GPCR—POMC—polycystic ovary syndrome	2.67e-05	0.000483	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling Pathways—PRL—polycystic ovary syndrome	2.67e-05	0.000481	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling by GPCR—AKT2—polycystic ovary syndrome	2.57e-05	0.000464	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling Pathways—ADRB2—polycystic ovary syndrome	2.53e-05	0.000457	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling Pathways—GNAS—polycystic ovary syndrome	2.35e-05	0.000423	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling Pathways—NCOR1—polycystic ovary syndrome	2.23e-05	0.000403	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling Pathways—NRG1—polycystic ovary syndrome	2.19e-05	0.000396	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling Pathways—IRS2—polycystic ovary syndrome	1.88e-05	0.000339	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling Pathways—LEP—polycystic ovary syndrome	1.84e-05	0.000332	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling Pathways—IRS1—polycystic ovary syndrome	1.64e-05	0.000296	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling Pathways—POMC—polycystic ovary syndrome	1.58e-05	0.000285	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling Pathways—INS—polycystic ovary syndrome	1.57e-05	0.000283	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling Pathways—IGF1—polycystic ovary syndrome	1.52e-05	0.000274	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling Pathways—AKT2—polycystic ovary syndrome	1.52e-05	0.000274	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling Pathways—SERPINE1—polycystic ovary syndrome	1.44e-05	0.00026	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling by GPCR—IL6—polycystic ovary syndrome	1.16e-05	0.00021	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling Pathways—VEGFA—polycystic ovary syndrome	9.92e-06	0.000179	CbGpPWpGaD
Metaraminol—ADRA1A—Signaling Pathways—IL6—polycystic ovary syndrome	6.86e-06	0.000124	CbGpPWpGaD
